TherapeuticsMD share price logo

TherapeuticsMD

NASDAQ: TXMD

$1.80

-0.03

(-1.64%)

as on

TherapeuticsMD Stock Performance

as on October 31, 2026 at 2:16 pm IST

  • Day's High

    $1.80
    $1.81

    0.56%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.11
    $2.95
    downward going graph

    38.33%

    Downside

    63.89%

    Upside

    downward going graph

TherapeuticsMD share price movements today

Previous Close
$1.83
Open
$1.80
Volume
76.3K
Market Cap
$20.7M
Day's Low - High
$1.80 - $1.81
52 Week Low - High
$1.11 - $2.95

TherapeuticsMD Historical Returns

1 Month Return
-9.85 %
3 Month Return
-9.85 %
1 Year Return
+ 47.58 %
3 Year Return
-11.59 %
5 Year Return
-94.97 %

TherapeuticsMD Stock Fundamentals & Key Indicators

Check TherapeuticsMD market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$20.7M

EPS (TTM)

-0.0188

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.81%

PE Ratio (TTM)

-95.21

Industry PE ratio

-0.80

PEG Ratio

-0.09

EBITDA

-4.0M

Revenue (TTM)

3.3M

Profit Margin

89.94%

Return On Equity TTM

-0.80%

TherapeuticsMD vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of TherapeuticsMD with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Hold$20.7M-94.97%-95.2189.94%0.00%
Buy$42.5BNA64.6447.54%1.06%
StrongBuy$25.2B211.14%19.4086.14%0.00%
Buy$21.5B40.60%-52.0034.83%2.56%
Buy$43.8BNA20.6265.57%1.24%

Stock Returns calculator for TherapeuticsMD Stock including INR - Dollar returns

The TherapeuticsMD stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

TherapeuticsMD investment value today

Current value as on today

₹1,55,349

Returns

₹55,349

(+55.35%)

Returns from TherapeuticsMD Stock

₹45,161 (+45.16%)

Dollar Impact

₹10,187 (+10.19%)

Analyst Recommendation on TherapeuticsMD Stock

Based on 6 analysts

HOLD

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'HOLD' rating for TherapeuticsMD. Average target price of $5

TherapeuticsMD Share Price Target

Get share price movements and forecasts by analysts on TherapeuticsMD.

What analysts predicted

64%UPSIDE

Target Price

$5

Current Price

$1.8

Analyzed by

6 Analysts

Target

$5.00

TherapeuticsMD target price $5, a slight upside of 64% compared to current price of $1.8. According to 6 analysts rating.

Indian Investors' Interest in TherapeuticsMD Stock

Search interest for TherapeuticsMD Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-21% versus previous 30 day period

TherapeuticsMD Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-1
-2
-1
0
-1
0
0
-1
0
0
EBITDA
0
0
0
0
-1
0
0
-3
0
0
Interest Expense
-
0
0
-
0
0
0
0
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
-1
0
0
0
0
0
0
0
0
Income Tax Expense
-
-
-
0
0
-
-
0
-
-
Net Income
0
-1
0
0
0
0
0
0
0
0
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
62.14%

TherapeuticsMD Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
16
16
49
64
2
69
1
1
3
Gross Profit
14
13
43
48
1
68
1
1
3
Operating Income
-77
-130
-151
-155
-79
10
-8
-4
-4
EBITDA
-76
-127
-158
-153
-78
11
-7
-4
-3
Interest Expense
-
4
17
28
32
-
0
-
0
Depreciation
0
0
1
4
0
1
0
0
1
Income Before Tax
-76
-132
-176
-183
-79
1
-7
-2
0
Income Tax Expense
-
-
-
-
-
-
0
0
-
Net Income
-76
-132
-176
-183
-172
111
-10
-2
0
Net Profit Margin
84.28%
83.00%
87.24%
75.37%
45.51%
98.00%
100.00%
100.00%
100.00%

TherapeuticsMD Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
-1
0
0
0
0
0
0
0
0
Operating Cash Flow
0
0
0
0
0
0
1
0
0
0
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-
-
-
-
-
-
-
-
-
-
Change in Cash
0
0
0
0
0
0
1
0
0
0

TherapeuticsMD Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Net Income
-76
-132
-176
-183
-79
1
-7
-2
0
Operating Cash Flow
-76
-106
-165
-159
-147
-4
-48
0
2
Investing Cash Flow
0
-21
-23
-1
-2
223
-
-
-
Financing Cash Flow
72
162
188
80
134
-235
3
-
-
Change in Cash
-4
34
0
-80
-15
-15
-44
0
2

Global Institutional Holdings in TherapeuticsMD

Check out the Institutions with significant holdings in TherapeuticsMD.

Funds
Holdings
Vanguard
3.41%
VANGUARD INDEX FUNDS
3.06%
Fidelity Concord Street Trust
0.78%
Bridgeway Funds, Inc.
0.15%
Bridgeway
0.14%

Insights on TherapeuticsMD

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 724.0K → 869.0K (in $), with an average increase of 16.7% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -619.0K → 155.0K (in $), with an average increase of 395.1% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, TXMD stock has moved up by 53.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 85.3% return, outperforming this stock by 31.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, SANDOZ GROUP AG SPONSORED ADS Switzerland has given 115.2% return, outperforming this stock by 128.5%

About TherapeuticsMD

TherapeuticsMD, Inc. is a U.S.-based pharmaceutical company dedicated to women's health. Its marketed portfolio includes IMVEXXY, prescribed for moderate to severe dyspareunia; BIJUVA, a bio-identical hormone replacement therapy combining 17ß-estradiol and progesterone, used to alleviate moderate to severe vasomotor symptoms; and ANNOVERA, an innovative vaginal ring designed for contraception. In its developmental pipeline, TherapeuticsMD is advancing several preclinical candidates: TX-005HR, a transdermal cream containing only progesterone; TX-006HR, another transdermal cream formulated with both estradiol and progesterone; TX-007HR and TX-008HR, both experimental transdermal patches; and TX-009HR, an oral formulation of progesterone and estradiol. Beyond its core pharmaceutical offerings, the company produces and distributes both branded and generic prescription prenatal vitamins, notably under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 labels. Its prescription medications and prenatal vitamin lines reach consumers through established channels, including wholesale and retail pharmacy distributors. Established in 2008, TherapeuticsMD, Inc. maintains its corporate headquarters in Boca Raton, Florida.
OrganisationTherapeuticsMD
Headquarters951 Yamato Road, Boca Raton, FL, 33431, US
IndustryDrug Manufacturers - Specialty & Generic
CEOMarlan D. Walker

Key Management of TherapeuticsMD

Name

Title

Mr. Marlan D. Walker J.D.

Chief Executive Officer

Mr. Joseph A. Ziegler

Principal Financial & Accounting Officer

FAQs

What is TherapeuticsMD share price today?

TherapeuticsMD share price today is $1.80 as on at the close of the market. TherapeuticsMD share today touched a day high of $1.81 and a low of $1.80.

What is the 52 week high and 52 week low for TherapeuticsMD share?

TherapeuticsMD share touched a 52 week high of $2.95 on and a 52 week low of $1.11 on . TherapeuticsMD stock price today i.e. is closed at $1.80,which is 38.98% down from its 52 week high and 62.16% up from its 52 week low.

What is TherapeuticsMD's market capitalisation today?

TherapeuticsMD market capitalisation is $0.00T as on .

How to invest in TherapeuticsMD Stock (TXMD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for TherapeuticsMD on INDmoney app. Click on Buy button.

What is the minimum amount required to buy TherapeuticsMD Stock (TXMD) from India?

Indian investors can start investing in TherapeuticsMD (TXMD) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in TherapeuticsMD stock (as per the Rupee-Dollar exchange rate as on ). Based on TherapeuticsMD share’s latest price of $1.80 as on October 31, 2026 at 8:46 am IST, you will get 5.5556 shares of TherapeuticsMD. Learn more about fractional shares .

What are the returns that TherapeuticsMD has given to Indian investors in the last 5 years?

TherapeuticsMD stock has given -94.97% share price returns and 27.22% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?